Abstract: composition 'which is adapted for oral consumption and which comprises: (i) a PPAR ligand; such as EPA or DHA (ii) an oestrogen receptor binding agent; such as soy isof lavones (iii) an agent that is involved in the post-translational modification of collagen; such as ascorbic acid and (iv) a carotenoid, wherein the composition is substantially free from added zinc and/or selenium, can provide an anti-ageing effect on skin and may be used to increase collagen synthesis in skin.
| # | Name | Date |
|---|---|---|
| 1 | 2164-MUMNP-2008-FORM 3(10-10-2008).pdf | 2008-10-10 |
| 2 | 2164-MUMNP-2008-FORM 2(TITLE PAGE)-(10-10-2008).pdf | 2008-10-10 |
| 3 | 2164-MUMNP-2008-FORM 2(COMPLETE)-(10-10-2008).pdf | 2008-10-10 |
| 4 | 2164-MUMNP-2008-DRAWING(10-10-2008).pdf | 2008-10-10 |
| 5 | 2164-MUMNP-2008-DESCRIPTION(COMPLETE)-(10-10-2008).pdf | 2008-10-10 |
| 6 | 2164-MUMNP-2008-CORRESPONDENCE(10-10-2008).pdf | 2008-10-10 |
| 7 | 2164-MUMNP-2008-CLAIMS(10-10-2008).pdf | 2008-10-10 |
| 8 | 2164-MUMNP-2008-CORRESPONDENCE(14-10-2008).pdf | 2008-10-14 |
| 9 | 2164-MUMNP-2008-FORM 3(16-08-2011).pdf | 2011-08-16 |
| 10 | 2164-MUMNP-2008-REPLY TO EXAMINATION REPORT(12-10-2012).pdf | 2012-10-12 |
| 11 | 2164-MUMNP-2008-GENERAL POWER OF ATTORNEY12-10-2012).pdf | 2012-10-12 |
| 12 | 2164-MUMNP-2008-EP DOCUMENT(12-10-2012).pdf | 2012-10-12 |
| 13 | 2164-MUMNP-2008-CLAIMS(MARKED COPY)-(12-10-2012).pdf | 2012-10-12 |
| 14 | 2164-MUMNP-2008-CLAIMS(AMENDED)-(12-10-2012).pdf | 2012-10-12 |
| 15 | 2164-MUMNP-2008-ANNEXURE TO FORM 3(12-10-2012).pdf | 2012-10-12 |
| 16 | 2164-MUMNP-2008-FORM 3(10-12-2013).pdf | 2013-12-10 |
| 17 | 2164-MUMNP-2008-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(10-10-2014).pdf | 2014-10-10 |
| 18 | 2164-MUMNP-2008CORRESPONDENCE(31-10-2014).pdf | 2014-10-31 |
| 19 | 2164-MUMNP-2008-FORM 3(11-11-2014).pdf | 2014-11-11 |
| 20 | 2164-MUMNP-2008-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(23-12-2015).pdf | 2015-12-23 |
| 21 | abstract1.jpg | 2018-08-09 |
| 22 | 2164-MUMNP-2008_EXAMREPORT.pdf | 2018-08-09 |
| 23 | 2164-mumnp-2008-wo international publication report a1.pdf | 2018-08-09 |
| 24 | 2164-MUMNP-2008-REPLY TO HEARING(14-1-2016).pdf | 2018-08-09 |
| 25 | 2164-MUMNP-2008-REPLY TO EXAMINATION REPORT(5-9-2012).pdf | 2018-08-09 |
| 26 | 2164-mumnp-2008-pct-isa-210.pdf | 2018-08-09 |
| 27 | 2164-mumnp-2008-pct-ipea-416.pdf | 2018-08-09 |
| 28 | 2164-mumnp-2008-pct-ipea-409.pdf | 2018-08-09 |
| 29 | 2164-MUMNP-2008-OTHER DOCUMENT(5-9-2012).pdf | 2018-08-09 |
| 30 | 2164-MUMNP-2008-MARKED COPY (14-1-2016).pdf | 2018-08-09 |
| 31 | 2164-mumnp-2008-form 5.pdf | 2018-08-09 |
| 32 | 2164-mumnp-2008-form 3.pdf | 2018-08-09 |
| 33 | 2164-MUMNP-2008-Form 3-071015.pdf | 2018-08-09 |
| 34 | 2164-MUMNP-2008-FORM 3(8-8-2012).pdf | 2018-08-09 |
| 35 | 2164-MUMNP-2008-FORM 3(3-8-2010).pdf | 2018-08-09 |
| 36 | 2164-MUMNP-2008-FORM 3(25-4-2015).pdf | 2018-08-09 |
| 37 | 2164-MUMNP-2008-FORM 3(24-2-2010).pdf | 2018-08-09 |
| 38 | 2164-MUMNP-2008-FORM 3(23-1-2013).pdf | 2018-08-09 |
| 39 | 2164-MUMNP-2008-FORM 3(22-6-2013).pdf | 2018-08-09 |
| 40 | 2164-MUMNP-2008-FORM 3(21-5-2014).pdf | 2018-08-09 |
| 41 | 2164-MUMNP-2008-FORM 3(18-2-2011).pdf | 2018-08-09 |
| 42 | 2164-MUMNP-2008-FORM 3(13-2-2012).pdf | 2018-08-09 |
| 43 | 2164-mumnp-2008-form 2.pdf | 2018-08-09 |
| 44 | 2164-mumnp-2008-form 2(title page).pdf | 2018-08-09 |
| 45 | 2164-MUMNP-2008-FORM 2(TITLE PAGE)-(GRANTED)-(27-1-2016).pdf | 2018-08-09 |
| 46 | 2164-MUMNP-2008-FORM 2(GRANTED)-(27-1-2016).pdf | 2018-08-09 |
| 47 | 2164-MUMNP-2008-FORM 2 (TITLE PAGE)(14-1-2016).pdf | 2018-08-09 |
| 48 | 2164-MUMNP-2008-FORM 18(21-1-2010).pdf | 2018-08-09 |
| 49 | 2164-MUMNP-2008-FORM 13(8-2-2012).pdf | 2018-08-09 |
| 50 | 2164-mumnp-2008-form 1.pdf | 2018-08-09 |
| 51 | 2164-mumnp-2008-drawing.pdf | 2018-08-09 |
| 52 | 2164-MUMNP-2008-DRAWING(GRANTED)-(27-1-2016).pdf | 2018-08-09 |
| 53 | 2164-MUMNP-2008-DESCRIPTION(GRANTED)-(27-1-2016).pdf | 2018-08-09 |
| 54 | 2164-mumnp-2008-correspondence.pdf | 2018-08-09 |
| 55 | 2164-MUMNP-2008-Correspondence-191214.pdf | 2018-08-09 |
| 56 | 2164-MUMNP-2008-Correspondence-140815.pdf | 2018-08-09 |
| 57 | 2164-MUMNP-2008-CORRESPONDENCE-120315.pdf | 2018-08-09 |
| 58 | 2164-MUMNP-2008-Correspondence-090216.pdf | 2018-08-09 |
| 59 | 2164-MUMNP-2008-CORRESPONDENCE(IPO)-(FER)-(7-3-2012).pdf | 2018-08-09 |
| 60 | 2164-MUMNP-2008-CORRESPONDENCE(IPO)-(27-1-2016).pdf | 2018-08-09 |
| 61 | 2164-MUMNP-2008-CORRESPONDENCE(9-5-2013).pdf | 2018-08-09 |
| 62 | 2164-MUMNP-2008-CORRESPONDENCE(21-4-2014).pdf | 2018-08-09 |
| 63 | 2164-MUMNP-2008-CORRESPONDENCE(21-1-2010).pdf | 2018-08-09 |
| 64 | 2164-mumnp-2008-claims.pdf | 2018-08-09 |
| 65 | 2164-MUMNP-2008-CLAIMS(GRANTED)-(27-1-2016).pdf | 2018-08-09 |
| 66 | 2164-MUMNP-2008-CLAIMS(14-1-2016).pdf | 2018-08-09 |
| 67 | 2164-MUMNP-2008-ANNEXURE TO FORM 3(5-9-2012).pdf | 2018-08-09 |
| 68 | 2164-MUMNP-2008-ABSTRACT(GRANTED)-(27-1-2016).pdf | 2018-08-09 |
| 69 | 2164-MUMNP-2008-RELEVANT DOCUMENTS [09-09-2021(online)].pdf | 2021-09-09 |
| 70 | 2164-MUMNP-2008-RELEVANT DOCUMENTS [14-09-2022(online)].pdf | 2022-09-14 |
| 71 | 2164-MUMNP-2008-RELEVANT DOCUMENTS [29-09-2023(online)].pdf | 2023-09-29 |
| 72 | 2164-MUMNP-2008-FORM-27 [28-08-2024(online)].pdf | 2024-08-28 |